The present invention relates to sintered coatings for implantable prostheses, particularly those in which at least one layer of aspherical metal particles is disposed upon a layer of spherical metal particles.
There are a number of design criteria which have long been sought for segmental bone replacement implants including (1) the implant should last the lifetime of the patient without losing function or initiating any adverse process response; (2) the implant should restore the normal function of the bone in which it is implanted; and (3) the implant should be producible on a commercial scale. To satisfy the foregoing criteria, not only should the implant support the imposed load, often of a fluctuating nature, but the interface between the implant and the bone should also withstand the load requirement.
A plastic cement such as polymethyl methacrylate is often used to affix an implant to bone as well as to improve the fit between the implant and the bone. Implants also have been provided with porous coatings which mate with the bone and invite bone ingrowth such that, after a period of time, the prosthesis becomes integrated into the bone structure. Typical of such coatings are the those disclosed in U.S. Pat. Nos. 3,855,638; 4,206,516; 4,156,943; and 4,612,160.
Ceramic coatings have also been used to good effect and often are particularly desirable because of the affinity between bone and ceramic materials such as alumina (Al2O3). Typical of such coatings are those disclosed in U.S. Pat. Nos. 4,145,764 and 4,483,678 to which are particularly concerned with dental implants, and U.S. Pat. Nos. 4,309,488 and 4,846,837, which more broadly disclose implantable bone replacement material for use throughout the body.
Other work has utilized highly convoluted surfaces on the implant. U.S. Pat. Nos. 5,368,881 and 5,658,333 show use of non-spherical powder to produce a roughened surface for prosthesis. These surfaces, however, are known to have little to no inter-connected porosity.
There is a continued need in the art for prosthesis surfaces with improved properties.
One aspect of the present invention concerns implants and other articles having an outer surface that bears at least two layers of metal particles. In preferred embodiments, the article has an outermost layer and an intermediate layer disposed between the outermost layer and the article's outer surface. The outermost layer consists essentially of aspherical metallic particles having a mean particle size of about 50 to 500 microns. The intermediate layer consists essentially of substantially spherical metallic particles having a mean particle size of about 50 to 500 microns.
The aspherical metallic particles and spherical metallic particles can each, independently, comprise one or more metals such as cobalt, chromium, molybdenum, tantalum, and titanium. In some embodiments, the spherical and aspherical metallic particles have the same composition as the substrate upon which they are disposed, i.e., the article or at least its outer surface thereof. In certain embodiments, the substrate, the spherical metallic particles and the aspherical metallic particles comprise titanium, although in other embodiments they comprise cobalt and chromium.
The substrate can comprise one or more metals such as cobalt, chromium, molybdenum, tantalum, and titanium. Some articles or prostheses utilize a substrate that is of a different composition than the particles. In some embodiments, the substrate comprises an alloy composition (Ti-6Aluminum-4-Vanadium, for example).
In some embodiments, the layer(s) of spherical metallic particles and layer(s) of aspherical metallic particles have a combined thickness of 100 microns to 2.5 mm on the substrate.
The present invention also provides methods for making the coated articles described herein. In certain embodiments, the methods comprise
In some aspects, the invention relate to a process where metallic particles are metallurgically sintered onto the surface of a solid metal substrate (or the surface of the implant/article). The surface coating can yield a highly rough, highly porous structure. In some embodiments, the porous coating will yield a volume porosity of between about 20% to about 80%. In other embodiments, the porosity is between about 55% and about 75%.
The invention also relates to methods for implanting a prosthesis of the invention in a human or animal body. Such implantation generally involves placing the implant within or adjacent to bone.
In the instant invention, a sintered metal coating is placed on a substrate. In particular, the coating comprises a first section of symmetrical particles applied to at least one surface of the substrate and a second section of the coating which is formed from asymmetrical particles and applied to the first section of the coating. The layers of particles are metallurgically sintered to each other and onto the solid substrate.
The coated surfaces of the invention are suitable for implantable medical devices. The implantation of the devices generally involves placing the implant within or adjacent to bone. The surfaces of the invention have good roughness and porosity properties which allow the devices to have greater initial fixation and greater bone ingrowth than traditional devices. The greater initial fixation should result in a faster recovery for the recipient of the device.
The implantable medical devices include implantable prostheses. The invention, for example, can be applied to all types of metal prostheses which are attachable to bone at any location within the body. Examples of implantable prostheses include facial bones, hips, knees or another joints, and dental implants.
Typically, the coating is applied to the surface of the substrate (i.e., the article or prostheses, in some embodiments) using conventional sintering techniques known in the art. The sintering can be performed in a high temperature, vacuum furnace. Various companies provide coating services for metal prostheses which can be used in the practice of the invention, including Bio-Vac Inc. (Southfield, Mich.), Hy-Vac Technologies, Inc. (Detroit, Mich.), and Astro Met, Inc. (Cincinnati, Ohio).
In the instant invention, the coatings may be placed on the surface in one or more applications. A layer of first particles (also referred to as powder or beads) is placed on the substrate surface. These first particles are spherical and can be applied as multiple coatings if desired. A second layer of particles, aspherical particles, is applied onto the first layer of particles. The second particles may also be applied as multiple coatings if desired.
The coating comprises sintered particles of biocompatible metal such as, for example, cobalt, chromium, molybdenum, tantalum, titanium, and mixtures thereof. Examples of suitable metals include pure tantalum, pure titanium, a titanium alloy (e.g., Ti 6Al 4V; ASTM-F136), and cobalt-chromium alloy (e.g., ASTM-F75). In some preferred embodiments, the metal coating will have the same composition as that of the underlying prosthesis.
One type of particles used in the instant invention are substantially spherically-shaped. That is, their cross-sections are substantially circular. For spherical particles, the diameter of a particle (and, hence, its size) is defined by reference to the longest chord between any two points on the surface of the particle. These spherical particles are metallic and have a particle size of 50-500 microns. In some embodiments, the particle size is 150-300 microns.
Other particles used in the invention have an irregular shape. These particles are substantially aspherical, e.g., the particles may have cross-sections which are irregular in form. The cross-sections can be irregular with aspect ratio not equal to 1. For ease of reference, the irregularly-shaped particles will be referred to herein as “aspherical particles.” The diameter (and, hence, the size) of aspherical particles is defined as the diameter of the smallest hole through which the particle may pass. These aspherical particles are metallic and have a particle size of 50-500 microns. In some embodiments, the particle size is 150-300 microns.
The spherical and aspherical particles may have a single modal or an at least bimodal particle size distribution. When at least bimodal particles are used, the particles can be achieved by mixing together at least two sets of sieve-selected particles having different mean diameters.
Typically, the layers of symmetrical and asymmetrical sintered particles have a combined thickness of least 100 microns. In some embodiments, the layers have a combined thickness of up to 2.5 mm. In other embodiments, the layers have a combined thickness of up to 2.0 mm. The layers can be made from any combination of symmetrical and asymmetrical particles so long as the symmetrical particles are applied to the substrate and the asymmetrical particles are applied to the symmetrical particles. That is to say, that the surface of the substrate should be in contact with predominately symmetrical particles. In some embodiments, the ratio of the thickness of the symmetrical to asymmetrical particles on the substrate is 90:10, 80:20, 70:30, 60:40, 50:50, 40:60, 30:70, 20:80, or 10:90.
An important quality of an implant with a coated surface is the strength of the bond between the coating and the underlying substrate. The bond strength of the instant coatings at the substrate interface enables it to withstand significant loads without a breakdown of the coating. In particular, the tensile strength of the bond is greater than between bone cement and a metal surface. In some embodiments, the bond strength is at least 4000 psi.
The following definitions are provided for the full understanding of terms used herein.
As used herein, the term “intermediate layer” refers to a layer that is positioned between the substrate and the outer layer.
The “metal particles” are also referred to as “metal powders”. In the case of symmetrical particles, they are also referred to as “beads”.
The term “prosthesis” is intended to refer to an artificial substitute of a part of the body. A prosthesis can be functional, cosmetic, or a combination of the two. One example of such a prosthesis is the femoral component for a hip prosthesis pictured in
When a surface is said to “bear” metal particles, the particles are affixed to the surface. Methods of affixing the particles, such as sintering, are well known to those skilled in the art.
Where a layer is said to be “consisting essentially of” a particular type of particles, it is intended that the majority of particles in that layer are of that type. Typically, at least 90% or 95% or 99% or the particles in the layer are of the designated type.
In some embodiments, a discrete barrier may not exist between the layers of beads. However, in such circumstances, the particles at the outermost portion of the coating (or outer layer) comprises a majority of irregular particles and the portion of the coating adjacent to the substrate (or intermediate layer) will have a majority of the particles being spherical.
The term “substantially spherical particles” refers to particles that whose chord between any two points varies by less than 20%.
The term “substantially aspherical particles” refers to particles whose shape causes them to fall outside of the definition of “substantially spherical particles” detailed above.
As used herein, the term “at least a bimodal size distribution” means that a plot of number of particles versus particle diameter has at least two discernible peaks. Such plots can be readily constructed using sieving techniques to construct a histogram or by simply counting and measuring particles for a representative portion of a coated prosthesis. In this connection, the diameter of a particle is defined as the longest chord between any two points on the surface of the particle.
The invention is illustrated by the following examples which are not intended to be limiting in nature.
Examples 1-4 were produced using −60+80 mesh, or 175-250 μm, spherical particles beneath −120+200 mesh, or 75-125 μm aspherical particles. The morphology of the aspherical particles is shown in
Samples were coated on the one flat surface for subsequent ease of analysis.
Scanning Electron Microscopy (SEM) was performed on the sintered samples. The four samples were rather similar in microstructure with Examples 2 and 4 appearing more “closed” in nature, and it was difficult to see the underlying beads for these two samples. A sample micrograph of each sample is shown in
The process yielded a coating that was considerably rougher than traditional beaded porous coatings qualitatively. The small powder yielded overall smaller pore size, and no dramatic increase in volume porosity to traditionally used beaded porous coatings.
Examples 5-10 were produced using −60+80 mesh spherical particles and −50+60 mesh, −60+80 mesh, −70+80 and/or −80+100 mesh aspherical particles. The powder exhibited a similar morphology to the initial powder, only larger in size. Samples were coated on the one flat surface for subsequent ease of analysis. Samples were coated as indicated in the table below, with coats applied in order from left to right. Porous coated and sintered samples were carefully cross-sectioned perpendicular to the coating and substrate, mounted, and metallurgically prepared for morphological evaluation. Photomicrographs of select cross-sections are shown in
The qualitative assessment of roughness of Examples 5-10 suggested that the larger the particle size, the greater the overall roughness of the coating. Initial volume porosity results also indicated higher porosity with the larger particles, at least in comparison to the previous −120+200 mesh particles used for Examples 1-4.
Examples 11-30 were produced using −60+80 mesh spherical particles and—varying distributions of sizes within −50+80 mesh of aspherical particles. The powder exhibited a similar morphology to the initial powder. Samples were coated on the one flat surface for subsequent ease of analysis. Samples were coated as indicated in the table below, with spherical particles applied to the metal substrate and aspherical particles applied on top of the spherical particles. Porous coated and sintered samples were carefully cross-sectioned perpendicular to the coating and substrate, mounted, and metallurgically prepared for morphological evaluation. Photomicrographs of representative cross-sections are shown in
In the foregoing specification, the concepts have been described with reference to specific embodiments. Many aspects and embodiments have been described above and are merely exemplary and not limiting. After reading this specification, skilled artisans appreciate that other aspects and embodiments are possible without departing from the scope of the invention. Moreover, one of ordinary skill in the art appreciates that various modifications and changes can be made without departing from the scope of the invention as set forth in the claims below. Accordingly, the specification and figures are to be regarded in an illustrative rather than a restrictive sense, and all such modifications are intended to be included within the scope of invention.
Benefits, other advantages, and solutions to problems have been described above with regard to specific embodiments. However, the benefits, advantages, solutions to problems, and any feature(s) that may cause the same to occur or become more pronounced are not to be construed as a critical, required, or essential feature of any or all the claims.
It is to be appreciated that certain features are, for clarity, described herein in the context of separate embodiments, but may also be provided in combination in a single embodiment. Conversely, various features that are, for brevity, described in the context of a single embodiment, may also be provided separately or in any subcombination. Further, reference to values stated in ranges include each and every value within that range.
This application claims benefit to U.S. Application No. 60/941,127, filed May 31, 2007, the disclosure of which is incorporated herein by reference in its entirety.
Number | Name | Date | Kind |
---|---|---|---|
3855638 | Pilliar | Dec 1974 | A |
4145764 | Suzuki et al. | Mar 1979 | A |
4156943 | Collier | Jun 1979 | A |
4206516 | Pilliar | Jun 1980 | A |
4309488 | Heide et al. | Jan 1982 | A |
4355428 | Deloison et al. | Oct 1982 | A |
4365358 | Judet et al. | Dec 1982 | A |
4483678 | Nishio et al. | Nov 1984 | A |
4494985 | Butler et al. | Jan 1985 | A |
4542539 | Rowe et al. | Sep 1985 | A |
4550448 | Kenna | Nov 1985 | A |
4611942 | Morse | Sep 1986 | A |
4612160 | Donlevy et al. | Sep 1986 | A |
4644942 | Sump | Feb 1987 | A |
4673409 | Van Kampen | Jun 1987 | A |
4693721 | Ducheyne | Sep 1987 | A |
4713076 | Draenert | Dec 1987 | A |
4735625 | Davidson | Apr 1988 | A |
4818559 | Hama et al. | Apr 1989 | A |
4828563 | Muller-Lierheim | May 1989 | A |
4846837 | Kurze et al. | Jul 1989 | A |
4878914 | Miwa et al. | Nov 1989 | A |
4883491 | Mallory et al. | Nov 1989 | A |
4904265 | MacCollum et al. | Feb 1990 | A |
4934381 | MacGregor | Jun 1990 | A |
4963151 | Ducheyne et al. | Oct 1990 | A |
5007931 | Smith | Apr 1991 | A |
5034186 | Shimamune et al. | Jul 1991 | A |
5108435 | Gustavson et al. | Apr 1992 | A |
5178201 | Ahlers | Jan 1993 | A |
5192324 | Kenna | Mar 1993 | A |
5217526 | Fife | Jun 1993 | A |
5258030 | Wolfarth et al. | Nov 1993 | A |
5263986 | Noiles et al. | Nov 1993 | A |
5306462 | Fife | Apr 1994 | A |
5368881 | Kelman et al. | Nov 1994 | A |
5405389 | Conta et al. | Apr 1995 | A |
5433750 | Gradinger et al. | Jul 1995 | A |
5441537 | Kenna | Aug 1995 | A |
5464440 | Johansson | Nov 1995 | A |
5489306 | Gorski | Feb 1996 | A |
5504300 | Devanathan et al. | Apr 1996 | A |
5507815 | Wagner et al. | Apr 1996 | A |
5645593 | Woods et al. | Jul 1997 | A |
5658333 | Kelman et al. | Aug 1997 | A |
5665121 | Gie et al. | Sep 1997 | A |
5672284 | Devanathan et al. | Sep 1997 | A |
5734959 | Krebs et al. | Mar 1998 | A |
5747106 | Matsunaga | May 1998 | A |
5947893 | Agrawal et al. | Sep 1999 | A |
6008432 | Taylor | Dec 1999 | A |
6033582 | Lee et al. | Mar 2000 | A |
6066176 | Oshida | May 2000 | A |
6083264 | Wood et al. | Jul 2000 | A |
6087553 | Cohen et al. | Jul 2000 | A |
6096140 | Susa et al. | Aug 2000 | A |
6149689 | Grundei | Nov 2000 | A |
6193761 | Treacy | Feb 2001 | B1 |
6193762 | Wagner et al. | Feb 2001 | B1 |
6206924 | Timm | Mar 2001 | B1 |
6261322 | Despres et al. | Jul 2001 | B1 |
6340360 | Lyles et al. | Jan 2002 | B1 |
6447550 | Hunter et al. | Sep 2002 | B1 |
6485521 | Say et al. | Nov 2002 | B1 |
6491723 | Beaty | Dec 2002 | B1 |
6514288 | Meulink et al. | Feb 2003 | B2 |
6544472 | Compton et al. | Apr 2003 | B1 |
6572654 | Santilli | Jun 2003 | B1 |
6582470 | Lee et al. | Jun 2003 | B1 |
6746488 | Bales | Jun 2004 | B1 |
6875386 | Ward et al. | Apr 2005 | B1 |
7001672 | Justin et al. | Feb 2006 | B2 |
7018418 | Amrich et al. | Mar 2006 | B2 |
7048870 | Ellingsen et al. | May 2006 | B1 |
7052518 | Irie et al. | May 2006 | B2 |
7208222 | Rolfe et al. | Apr 2007 | B2 |
7368065 | Yang et al. | May 2008 | B2 |
7501073 | Wen et al. | Mar 2009 | B2 |
7534451 | Erbe et al. | May 2009 | B2 |
7648735 | Hunter et al. | Jan 2010 | B2 |
7857860 | Saini et al. | Dec 2010 | B2 |
20010004711 | Lazzara et al. | Jun 2001 | A1 |
20020120344 | Meulink et al. | Aug 2002 | A1 |
20020151983 | Shetty | Oct 2002 | A1 |
20020173855 | Mansmann | Nov 2002 | A1 |
20030004578 | Brown et al. | Jan 2003 | A1 |
20030055511 | Schryver et al. | Mar 2003 | A1 |
20030065400 | Beam et al. | Apr 2003 | A1 |
20030130736 | Raab | Jul 2003 | A1 |
20030171053 | Sanders | Sep 2003 | A1 |
20030191533 | Dixon et al. | Oct 2003 | A1 |
20030206928 | Tormala et al. | Nov 2003 | A1 |
20030229399 | Namavar | Dec 2003 | A1 |
20040019132 | Long et al. | Jan 2004 | A1 |
20040037813 | Simpson et al. | Feb 2004 | A1 |
20040107002 | Katsuya | Jun 2004 | A1 |
20040149586 | Sul | Aug 2004 | A1 |
20040167632 | Wen et al. | Aug 2004 | A1 |
20040176854 | Hesseling et al. | Sep 2004 | A1 |
20040199261 | Jones | Oct 2004 | A1 |
20040243133 | Materna | Dec 2004 | A1 |
20050013973 | Richter et al. | Jan 2005 | A1 |
20050027366 | Saini et al. | Feb 2005 | A1 |
20050049715 | Ito et al. | Mar 2005 | A1 |
20050112397 | Rolfe et al. | May 2005 | A1 |
20050123672 | Justin et al. | Jun 2005 | A1 |
20050159820 | Yoshikawa et al. | Jul 2005 | A1 |
20050161120 | Inagaki et al. | Jul 2005 | A1 |
20050165494 | McLeod et al. | Jul 2005 | A1 |
20050167309 | Iwatschenko | Aug 2005 | A1 |
20050273176 | Ely et al. | Dec 2005 | A1 |
20060015187 | Hunter et al. | Jan 2006 | A1 |
20060085063 | Shastri et al. | Apr 2006 | A1 |
20060122706 | Lo | Jun 2006 | A1 |
20060127480 | Tobyn et al. | Jun 2006 | A1 |
20060129161 | Amrich et al. | Jun 2006 | A1 |
20060136071 | Maspero et al. | Jun 2006 | A1 |
20060178751 | Despres et al. | Aug 2006 | A1 |
20060190092 | Fridshtand et al. | Aug 2006 | A1 |
20060191610 | Roger | Aug 2006 | A1 |
20060229715 | Istephanous et al. | Oct 2006 | A1 |
20060235541 | Hodorek | Oct 2006 | A1 |
20060282172 | Namavar | Dec 2006 | A1 |
20070173952 | Hermansson et al. | Jul 2007 | A1 |
20070282455 | Luginbuehl et al. | Dec 2007 | A1 |
20080193956 | Kricka et al. | Aug 2008 | A1 |
20080195232 | Carr-Brendel et al. | Aug 2008 | A1 |
20090112315 | Fang et al. | Apr 2009 | A1 |
20090162235 | Kita et al. | Jun 2009 | A1 |
20090187255 | Jani et al. | Jul 2009 | A1 |
20090187256 | Rauguth et al. | Jul 2009 | A1 |
20090192610 | Case et al. | Jul 2009 | A1 |
20090270998 | Kokubo et al. | Oct 2009 | A1 |
20090305135 | Shi et al. | Dec 2009 | A1 |
20100075419 | Inagaki et al. | Mar 2010 | A1 |
20100094430 | Krumdieck | Apr 2010 | A1 |
20100121463 | Tormala et al. | May 2010 | A1 |
20100131074 | Shikinami | May 2010 | A1 |
20100168869 | Long et al. | Jul 2010 | A1 |
20100179667 | Day et al. | Jul 2010 | A1 |
20100222892 | Linares | Sep 2010 | A1 |
20110022180 | Melkent et al. | Jan 2011 | A1 |
20110022181 | Kasahara et al. | Jan 2011 | A1 |
20110067228 | Green | Mar 2011 | A1 |
Number | Date | Country | |
---|---|---|---|
20080300682 A1 | Dec 2008 | US |
Number | Date | Country | |
---|---|---|---|
60941127 | May 2007 | US |